These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 14027059)

  • 1. [Demonstration, by a pharmacological test, of relations between the metabolism of some pyridoxine derivatives and the antidepressive action, in the mouse, of monoamine oxidase inhibitor (IMAO)].
    DENYS A; LEVY J; MICHEL-BER E
    C R Hebd Seances Acad Sci; 1962 Nov; 255():2528-30. PubMed ID: 14027059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contribution to the study of the mechanism of antidepressive action of monoamine oxidase inhibitors (MAOI) at the level of the central nervous system in the mouse. II. Influence of some pyridoxine derivatives on the antidepressive action of MAOI].
    DENYS A; LEVY J; MICHEL-BER E
    J Physiol (Paris); 1963; 55():381-404. PubMed ID: 14027058
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relations between inhibition of cerebral monoamine oxidase in mice and the pyridoxal-5-phosphate-monoamine oxidase inhibitor pharmacological antagonism in the presence of 3,4-dihydroxyphenylalanine].
    Lévy J; Michel-Ber E
    J Physiol (Paris); 1965; 57(4):475-83. PubMed ID: 5848057
    [No Abstract]   [Full Text] [Related]  

  • 4. [Poisoning by hydrazine derivatives (review of the literature)].
    Bogdanov NA
    Voen Med Zh; 1972 Nov; 11():46-9. PubMed ID: 4567431
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: The "pharmacological bridge": a view from the clinical shores.
    Sack R; Goodwin FK
    Psychopharmacol Bull; 1974 Oct; 10(4):52-3. PubMed ID: 4431876
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of heterocyclic hydrazones of pyridoxal phosphate. Coenzymic action].
    Duhault J; Gonnard P; Fenard S
    Bull Soc Chim Biol (Paris); 1967; 49(2):177-90. PubMed ID: 6055270
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors.
    López-Muñoz F; Alamo C; Juckel G; Assion HJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):555-9. PubMed ID: 18004120
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACTION OF DOPA AND MONOAMINE OXIDASE INHIBITION BY IPRONIAZID ON THE BRAIN].
    MONNIER M; GRABER S
    Schweiz Arch Neurol Neurochir Psychiatr; 1963; 92():410-4. PubMed ID: 14059162
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitamin B6 related epilepsy during childhood.
    Wang HS; Kuo MF
    Chang Gung Med J; 2007; 30(5):396-401. PubMed ID: 18062169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics.
    Fangmann P; Assion HJ; Juckel G; González CA; López-Muñoz F
    J Clin Psychopharmacol; 2008 Feb; 28(1):1-4. PubMed ID: 18204333
    [No Abstract]   [Full Text] [Related]  

  • 12. [Irreversible, non-selective monoamine oxidase inhibitors].
    Castberg I; Spigset O
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):746-8. PubMed ID: 19373300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the bottom line for dietary guidelines when taking monoamine oxidase inhibitors?
    Marcason W
    J Am Diet Assoc; 2005 Jan; 105(1):163. PubMed ID: 15635366
    [No Abstract]   [Full Text] [Related]  

  • 15. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 16. [MONOAMINE OXIDASE INHIBITORS AS ANTIDEPRESSANTS].
    NISHINUMA K
    Seishin Shinkeigaku Zasshi; 1963 Jul; 65():614-9. PubMed ID: 14053750
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary trials of a new monoamine oxidase inhibitor, hydrazino-2-octane (D-1514), as an antidepressive agent].
    DELAY J; DENIKER P; GENESTET D; PERIER M; CONTE C
    Encephale; 1962; 51():517-30. PubMed ID: 14026655
    [No Abstract]   [Full Text] [Related]  

  • 18. Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors.
    Vilches-Herrera M; Miranda-Sepúlveda J; Rebolledo-Fuentes M; Fierro A; Lühr S; Iturriaga-Vasquez P; Cassels BK; Reyes-Parada M
    Bioorg Med Chem; 2009 Mar; 17(6):2452-60. PubMed ID: 19243954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
    Kitaichi Y
    Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.